BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33157157)

  • 1. HOTAIR and androgen receptor synergistically increase GLI2 transcription to promote tumor angiogenesis and cancer stemness in renal cell carcinoma.
    Bai JY; Jin B; Ma JB; Liu TJ; Yang C; Chong Y; Wang X; He D; Guo P
    Cancer Lett; 2021 Feb; 498():70-79. PubMed ID: 33157157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YAP Promotes VEGFA Expression and Tumor Angiogenesis Though Gli2 in Human Renal Cell Carcinoma.
    Xu S; Zhang H; Chong Y; Guan B; Guo P
    Arch Med Res; 2019 May; 50(4):225-233. PubMed ID: 31518897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of lncRNA HOTAIR alleviates RCC angiogenesis through regulating miR-126/EGFL7 axis.
    Guo YP; Wang ZF; Li N; Lei QQ; Cheng Q; Shi LG; Zhou SL; Wang XH; Sun Y; Kong LF
    Am J Physiol Cell Physiol; 2021 May; 320(5):C880-C891. PubMed ID: 33502949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR.
    You B; Sun Y; Luo J; Wang K; Liu Q; Fang R; Liu B; Chou F; Wang R; Meng J; Huang CP; Yeh S; Chang C; Xu W
    Oncogene; 2021 Mar; 40(9):1674-1689. PubMed ID: 33510354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals.
    Zhai W; Sun Y; Guo C; Hu G; Wang M; Zheng J; Lin W; Huang Q; Li G; Zheng J; Chang C
    Cell Death Differ; 2017 Sep; 24(9):1502-1517. PubMed ID: 28644440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status.
    Chen Y; Sun Y; Rao Q; Xu H; Li L; Chang C
    Oncotarget; 2015 Oct; 6(31):31203-15. PubMed ID: 26304926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2α/C-MYC axis under hypoxia.
    Zhai W; Sun Y; Jiang M; Wang M; Gasiewicz TA; Zheng J; Chang C
    Oncogene; 2016 Sep; 35(37):4866-80. PubMed ID: 26973243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA HOTAIR promotes cell migration by upregulating insulin growth factor-binding protein 2 in renal cell carcinoma.
    Katayama H; Tamai K; Shibuya R; Nakamura M; Mochizuki M; Yamaguchi K; Kawamura S; Tochigi T; Sato I; Okanishi T; Sakurai K; Fujibuchi W; Arai Y; Satoh K
    Sci Rep; 2017 Sep; 7(1):12016. PubMed ID: 28931862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA HOTAIR regulates HIF-1α/AXL signaling through inhibition of miR-217 in renal cell carcinoma.
    Hong Q; Li O; Zheng W; Xiao WZ; Zhang L; Wu D; Cai GY; He JC; Chen XM
    Cell Death Dis; 2017 May; 8(5):e2772. PubMed ID: 28492542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-203 Inhibits Long Noncoding RNA HOTAIR and Regulates Tumorigenesis through Epithelial-to-mesenchymal Transition Pathway in Renal Cell Carcinoma.
    Dasgupta P; Kulkarni P; Majid S; Shahryari V; Hashimoto Y; Bhat NS; Shiina M; Deng G; Saini S; Tabatabai ZL; Yamamura S; Tanaka Y; Dahiya R
    Mol Cancer Ther; 2018 May; 17(5):1061-1069. PubMed ID: 29440295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA-SERB promotes vasculogenic mimicry (VM) formation and tumor metastasis in renal cell carcinoma.
    Tang S; Chen F; Zhang J; Chang F; Lv Z; Li K; Li S; Hu Y; Yeh S
    J Biol Chem; 2024 May; 300(5):107297. PubMed ID: 38641065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA HOTAIR promotes renal cell carcinoma malignancy through alpha-2, 8-sialyltransferase 4 by sponging microRNA-124.
    Pan Y; Wu Y; Hu J; Shan Y; Ma J; Ma H; Qi X; Jia L
    Cell Prolif; 2018 Dec; 51(6):e12507. PubMed ID: 30105850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney cancer: AR promotes RCC via lncRNA interaction.
    Fenner A
    Nat Rev Urol; 2016 May; 13(5):242. PubMed ID: 27041208
    [No Abstract]   [Full Text] [Related]  

  • 14. Long non-coding RNA HOTAIR induces GLI2 expression through Notch signalling in systemic sclerosis dermal fibroblasts.
    Wasson CW; Ross RL; Wells R; Corinaldesi C; Georgiou IC; Riobo-Del Galdo NA; Del Galdo F
    Arthritis Res Ther; 2020 Dec; 22(1):286. PubMed ID: 33303026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCAR4 activates GLI2 signaling in prostate cancer to contribute to castration resistance.
    Cai Z; Wu Y; Li Y; Ren J; Wang L
    Aging (Albany NY); 2018 Dec; 10(12):3702-3712. PubMed ID: 30513511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor β promotes renal cell carcinoma progression via regulating LncRNA HOTAIR-miR-138/200c/204/217 associated CeRNA network.
    Ding J; Yeh CR; Sun Y; Lin C; Chou J; Ou Z; Chang C; Qi J; Yeh S
    Oncogene; 2018 Sep; 37(37):5037-5053. PubMed ID: 29789714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptors.
    Li N; Chen M; Truong S; Yan C; Buttyan R
    Prostate; 2014 Oct; 74(14):1400-10. PubMed ID: 25132524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor (AR) signaling promotes RCC progression via increased endothelial cell proliferation and recruitment by modulating AKT → NF-κB → CXCL5 signaling.
    Guan Z; Li C; Fan J; He D; Li L
    Sci Rep; 2016 Nov; 6():37085. PubMed ID: 27848972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer.
    Zhao J; Du P; Cui P; Qin Y; Hu C; Wu J; Zhou Z; Zhang W; Qin L; Huang G
    Oncogene; 2018 Jul; 37(30):4094-4109. PubMed ID: 29706652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated Kras/YY1/ZNF322A/Shh transcriptional axis enhances neo-angiogenesis to promote lung cancer progression.
    Lin CC; Kuo IY; Wu LT; Kuan WH; Liao SY; Jen J; Yang YE; Tang CW; Chen YR; Wang YC
    Theranostics; 2020; 10(22):10001-10015. PubMed ID: 32929330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.